Laman Utama8AP • FRA
add
Agios Pharmaceuticals Inc
Tutup sebelumnya
€22.40
Julat hari
€24.20 - €24.20
Julat tahun
€24.20 - €58.00
Permodalan pasaran
1.46B USD
Bilangan Purata
3.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Stock Titan
3 jam lalu
Applied DNA Overcomes Delisting Threat: Successfully Maintains Nasdaq
Standards
5.47%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 10.73J | 51.06% |
Perbelanjaan pengendalian | 51.70J | 46.43% |
Pendapatan bersih | -96.52J | -0.61% |
Margin untung bersih | -899.56 | 33.40% |
Pendapatan bagi setiap syer | -1.74 | -1.16% |
EBITDA | -123.67J | -17.92% |
Kadar cukai berkesan | 8.42% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 893.71J | 15.03% |
Jumlah aset | 1.66B | 77.48% |
Jumlah liabiliti | 122.24J | -3.06% |
Jumlah ekuiti | 1.54B | — |
Syer tertunggak | 57.30J | — |
Harga kepada buku | 0.83 | — |
Pulangan pada aset | -18.09% | — |
Pulangan pada modal | -19.03% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -96.52J | -0.61% |
Tunai daripada operasi | -133.17J | -83.71% |
Tunai daripada pelaburan | -49.16J | -151.47% |
Tunai daripada pembiayaan | 4.84J | 471.66% |
Perubahan bersih dalam tunai | -177.48J | -843.48% |
Aliran tunai bebas | -108.06J | -155.48% |
Perihal
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Diasaskan
2008
Tapak web
Pekerja
487
